FindTrial
Sign In

Improving quality of life and normalizing BMI among PCOS diagnosed women using individualized Homoeopathic medicines

The role of individualized Homoeopathic medicine in improving quality of life and normalizing Body Mass Index among women with Polycystic Ovarian Syndrome - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073635
Enrollment
30
Registered
2024-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Individualized Homoeopathic Medicine: In globules of suitable potency based on susceptibility of the participant 2 doses of medicine once in 15 days for six months oral administration o

Sponsors

White memorial homoeo medical college hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women of age group from 18 to 45 years are included Patients already diagnosed with polycystic ovarian syndrome are included Patient with BMI value indicating overweight or obese

Exclusion criteria

Exclusion criteria: Patient with severe complications of PCOS Patients who had history of any psychological disorder from childhood Patients associated with any other systemic disorder malignancies SLE renal failure diabetes mellitus and secondary hypertension

Design outcomes

Primary

MeasureTime frame
USG for diagnostic confirmation before and after treatmentTimepoint: 1 year—

Secondary

MeasureTime frame
Change in score of PCOS questionnaireTimepoint: 1 year—

Countries

India

Contacts

Public ContactSHARON X

White memorial homoeo medical college hospital

divyapushparaj5@gmail.com8943868954

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026